Still Waiting for an Inflection and a Clearer View of Growth

Smartkarma
2024-05-14

⬆ $Cytek Biosciences (CTKB)$ - We reiterate our Market Perform rating on shares of Cytek following a mixed 1Q print (see first take here) which had a revenue performance ahead...


Continue reading on Smartkarma:- https://www.smartkarma.com/insights/still-waiting-for-an-inflection-and-a-clearer-view-of-growth?utm_source=tiger_community

By CGS CIMB Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cgs-cimb-research?utm_source=tiger_community

On Cytek Biosciences (CTKB):- https://www.smartkarma.com/entities/cytek-biosciences-inc?utm_source=tiger_community

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法
1